TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $120k
- Nov 3 · Routine
- Form 4 sales
- 260
- On record
- Form 144 notices
- 40
- Proposed sales
- Sold, last 30 days
- $120k
- 1 sale by 1 insider
- Sold, last 90 days
- $120k
- 1 sale by 1 insider
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Nov 3, 2026Routine
King Laura G., Director, sold 18.8% of their holdings
$120k4,800 shares at $25.00
- Nov 3, 2026Notice
King Laura G., Director, filed a notice to sell 4,800 shares
$120k4,800 shares
- Aug 19, 2026Notice
Burke William W, Director, filed a notice to sell 15,000 shares
$540M15,000 shares
- Aug 10, 2026No plan
Dodd Sheri Louise, Chief Executive Officer, sold 4.5% of their holdings
$323k10,978 shares at $29.44
- Aug 10, 2026Notice
Dodd Sheri Louise, Chief Executive Officer, filed a notice to sell 10,978 shares
$323k10,978 shares
- May 11, 2026No plan
Birkemeyer Elaine M., CHIEF FINANCIAL OFFICER, sold 3.4% of their holdings
$113k4,631 shares at $24.49
- May 11, 2026Notice
Birkemeyer Elaine M., CHIEF FINANCIAL OFFICER, filed a notice to sell 4,631 shares
$113k4,631 shares
- Feb 25, 2026Notice
Burns Kristie, Sr. VP Mktg & Clinical Affairs, filed a notice to sell 4,000 shares
$114k4,000 shares
- Feb 24, 2026No plan
Birkemeyer Elaine M., CHIEF FINANCIAL OFFICER, sold 5.4% of their holdings
$223k7,701 shares at $28.94
- Feb 24, 2026No plan
Burns Kristie, Sr. VP Mktg & Clinical Affairs, sold 7% of their holdings
$181k6,246 shares at $28.94
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Nov 6, 2026 | TCMD | Kiewiet Stephen A. | Chief Operating Officer | Awarded | 6,438 | 6,438 | SEC | ||
| Nov 3, 2026 | Nov 5, 2026 | TCMD | King Laura G. | Director | Sold | 4,800 | $25.00 | $120k | 20,769 | SEC |
| Aug 10, 2026 | Aug 12, 2026 | TCMD | Dodd Sheri Louise | Chief Executive Officer | Sold | 10,978 | $29.44 | $323k | 232,907 | SEC |
| May 11, 2026 | May 13, 2026 | TCMD | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Sold | 4,631 | $24.49 | $113k | 130,188 | SEC |
| May 6, 2026 | May 8, 2026 | TCMD | King Laura G. | Director | Awarded | 6,521 | 25,569 | SEC | ||
| May 6, 2026 | May 8, 2026 | TCMD | Washington Boyd Vindell | Director | Awarded | 6,521 | 41,768 | SEC | ||
| May 6, 2026 | May 8, 2026 | TCMD | Asbury Valerie L. | Director | Awarded | 6,521 | 55,343 | SEC | ||
| May 6, 2026 | May 8, 2026 | TCMD | Shafer David Brent | Director | Awarded | 6,521 | 55,343 | SEC | ||
| May 6, 2026 | May 8, 2026 | TCMD | Huggenberger Raymond | Director | Awarded | 6,521 | 62,841 | SEC | ||
| May 6, 2026 | May 8, 2026 | TCMD | Pearson Andrea | Director | Awarded | 6,521 | 7,373 | SEC | ||
| May 6, 2026 | May 8, 2026 | TCMD | Volkart Carmen B | Director | Awarded | 6,521 | 44,219 | SEC | ||
| May 6, 2026 | May 8, 2026 | TCMD | Burke William W | Director | Awarded | 6,521 | 55,041 | SEC | ||
| Mar 9, 2026 | Mar 11, 2026 | TCMD | Pearson Andrea | Director | Awarded | 852 | 852 | SEC | ||
| Feb 24, 2026 | Feb 26, 2026 | TCMD | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Sold | 7,701 | $28.94 | $223k | 134,819 | SEC |
| Feb 24, 2026 | Feb 26, 2026 | TCMD | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sold | 6,246 | $28.94 | $181k | 82,581 | SEC |
| Feb 24, 2026 | Feb 26, 2026 | TCMD | Dodd Sheri Louise | Chief Executive Officer | Sold | 10,993 | $28.94 | $318k | 243,885 | SEC |
| Feb 23, 2026 | Feb 24, 2026 | TCMD | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Sold | 5,518 | $28.29 | $156k | 142,520 | SEC |
| Feb 23, 2026 | Feb 24, 2026 | TCMD | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sold | 4,439 | $28.29 | $126k | 88,827 | SEC |
| Feb 23, 2026 | Feb 24, 2026 | TCMD | Dodd Sheri Louise | Chief Executive Officer | Sold | 15,240 | $28.29 | $431k | 254,878 | SEC |
| Feb 20, 2026 | Feb 24, 2026 | TCMD | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Awarded | 25,919 | 148,038 | SEC | ||
| Feb 20, 2026 | Feb 24, 2026 | TCMD | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Awarded | 14,671 | 93,266 | SEC | ||
| Feb 20, 2026 | Feb 24, 2026 | TCMD | Dodd Sheri Louise | Chief Executive Officer | Awarded | 47,967 | 270,118 | SEC | ||
| Feb 19, 2026 | Feb 23, 2026 | TCMD | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Awarded | 23,008 | 122,119 | SEC | ||
| Feb 19, 2026 | Feb 23, 2026 | TCMD | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Awarded | 6,194 | 78,595 | SEC | ||
| Feb 19, 2026 | Feb 23, 2026 | TCMD | Dodd Sheri Louise | Chief Executive Officer | Awarded | 48,672 | 222,151 | SEC | ||
| Jan 2, 2026 | Jan 6, 2026 | TCMD | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sold | 5,139 | $28.85 | $148k | 72,401 | SEC |
| Aug 8, 2025 | Aug 12, 2025 | TCMD | Dodd Sheri Louise | Chief Executive Officer | Sold | 7,762 | $12.36 | $96k | 173,479 | SEC |
| May 12, 2025 | May 14, 2025 | TCMD | Birkemeyer Elaine M. | Chief Financial Officer | Sold | 2,921 | $9.94 | $29k | 99,111 | SEC |
| May 8, 2025 | May 12, 2025 | TCMD | Dodd Sheri Louise | Chief Executive Officer | Sold | 3,149 | $9.83 | $31k | 181,241 | SEC |
| May 8, 2025 | May 9, 2025 | TCMD | Burke William W | Director | Sold | 3,300 | $9.67 | $32k | 48,520 | SEC |
| May 7, 2025 | May 9, 2025 | TCMD | Burke William W | Director | Awarded | 16,078 | 51,820 | SEC | ||
| May 7, 2025 | May 9, 2025 | TCMD | Asbury Valerie L. | Director | Awarded | 16,078 | 48,822 | SEC | ||
| May 7, 2025 | May 9, 2025 | TCMD | Huggenberger Raymond | Director | Awarded | 16,078 | 56,320 | SEC | ||
| May 7, 2025 | May 9, 2025 | TCMD | King Laura G. | Director | Awarded | 16,078 | 19,048 | SEC | ||
| May 7, 2025 | May 9, 2025 | TCMD | Shafer David Brent | Director | Awarded | 16,078 | 48,822 | SEC | ||
| May 7, 2025 | May 9, 2025 | TCMD | Volkart Carmen B | Director | Awarded | 16,078 | 37,698 | SEC | ||
| May 7, 2025 | May 9, 2025 | TCMD | Washington Boyd Vindell | Director | Awarded | 16,078 | 35,247 | SEC | ||
| Mar 11, 2025 | Mar 13, 2025 | TCMD | Reuvers Daniel L. | Director | Gift | 136,324 | 68,162 | SEC | ||
| Feb 25, 2025 | Feb 27, 2025 | TCMD | Birkemeyer Elaine M. | Chief Financial Officer | Sold | 2,066 | $14.51 | $30k | 102,032 | SEC |
| Feb 25, 2025 | Feb 27, 2025 | TCMD | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sold | 6,468 | $14.40 | $93k | 77,540 | SEC |
| Feb 25, 2025 | Feb 27, 2025 | TCMD | Reuvers Daniel L. | Director | Sold | 28,338 | $14.18 | $402k | 214,604 | SEC |
| Feb 24, 2025 | Feb 24, 2025 | TCMD | Reuvers Daniel L. | Director | Sold | 10,938 | $14.55 | $159k | 242,942 | SEC |
| Feb 24, 2025 | Feb 24, 2025 | TCMD | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sold | 4,830 | $14.65 | $71k | 84,008 | SEC |
| Feb 24, 2025 | Feb 24, 2025 | TCMD | Birkemeyer Elaine M. | Chief Financial Officer | Sold | 3,778 | $14.70 | $56k | 104,098 | SEC |
| Feb 20, 2025 | Feb 24, 2025 | TCMD | Reuvers Daniel L. | Director | Awarded | 15,853 | 253,880 | SEC | ||
| Feb 20, 2025 | Feb 24, 2025 | TCMD | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Awarded | 24,069 | 88,838 | SEC | ||
| Feb 20, 2025 | Feb 24, 2025 | TCMD | Birkemeyer Elaine M. | Chief Financial Officer | Awarded | 46,581 | 107,876 | SEC | ||
| Feb 20, 2025 | Feb 24, 2025 | TCMD | King Laura G. | Director | Awarded | 2,970 | 2,970 | SEC | ||
| Feb 20, 2025 | Feb 24, 2025 | TCMD | Dodd Sheri Louise | Chief Executive Officer | Awarded | 85,777 | 184,390 | SEC | ||
| Aug 12, 2024 | Aug 14, 2024 | TCMD | Ferstler Sherri Lee | Senior VP, Sales | Sold | 1,550 | $13.07 | $20k | 38,764 | SEC |
Sales, notices and lockups (300)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Nov 5, 2026 | King Laura G. | TCMD | Director | Form 4 sale | 4,800 | $120k | 18.8% | Routine | SEC |
| Nov 3, 2026 | Nov 3, 2026 | King Laura G. | TCMD | Director | Form 144 notice | 4,800 | $120k | Notice | SEC | |
| Aug 19, 2026 | Aug 20, 2026 | Burke William W | TCMD | Director | Form 144 notice | 15,000 | $540M | Notice | SEC | |
| Aug 10, 2026 | Aug 12, 2026 | Dodd Sheri Louise | TCMD | Chief Executive Officer | Form 4 sale | 10,978 | $323k | 4.5% | No plan | SEC |
| Aug 10, 2026 | Aug 10, 2026 | Dodd Sheri Louise | TCMD | Chief Executive Officer | Form 144 notice | 10,978 | $323k | Notice | SEC | |
| May 11, 2026 | May 13, 2026 | Birkemeyer Elaine M. | TCMD | CHIEF FINANCIAL OFFICER | Form 4 sale | 4,631 | $113k | 3.4% | No plan | SEC |
| May 11, 2026 | May 11, 2026 | Birkemeyer Elaine M. | TCMD | CHIEF FINANCIAL OFFICER | Form 144 notice | 4,631 | $113k | Notice | SEC | |
| Feb 25, 2026 | Feb 25, 2026 | Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Form 144 notice | 4,000 | $114k | Notice | SEC | |
| Feb 24, 2026 | Feb 26, 2026 | Birkemeyer Elaine M. | TCMD | CHIEF FINANCIAL OFFICER | Form 4 sale | 7,701 | $223k | 5.4% | No plan | SEC |
| Feb 24, 2026 | Feb 26, 2026 | Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Form 4 sale | 6,246 | $181k | 7.0% | No plan | SEC |
| Feb 24, 2026 | Feb 26, 2026 | Dodd Sheri Louise | TCMD | Chief Executive Officer | Form 4 sale | 10,993 | $318k | 4.3% | No plan | SEC |
| Feb 24, 2026 | Feb 24, 2026 | Dodd Sheri Louise | TCMD | Chief Executive Officer | Form 144 notice | 10,993 | $318k | Notice | SEC | |
| Feb 24, 2026 | Feb 24, 2026 | Birkemeyer Elaine M. | TCMD | CHIEF FINANCIAL OFFICER | Form 144 notice | 7,701 | $223k | Notice | SEC | |
| Feb 24, 2026 | Feb 24, 2026 | Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Form 144 notice | 6,246 | $181k | Notice | SEC | |
| Feb 23, 2026 | Feb 24, 2026 | Birkemeyer Elaine M. | TCMD | CHIEF FINANCIAL OFFICER | Form 4 sale | 5,518 | $156k | 3.7% | No plan | SEC |
| Feb 23, 2026 | Feb 24, 2026 | Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Form 4 sale | 4,439 | $126k | 4.8% | No plan | SEC |
| Feb 23, 2026 | Feb 24, 2026 | Dodd Sheri Louise | TCMD | Chief Executive Officer | Form 4 sale | 15,240 | $431k | 5.6% | No plan | SEC |
| Feb 23, 2026 | Feb 23, 2026 | Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Form 144 notice | 4,439 | $126k | Notice | SEC | |
| Feb 23, 2026 | Feb 23, 2026 | Dodd Sheri Louise | TCMD | Chief Executive Officer | Form 144 notice | 15,240 | $431k | Notice | SEC | |
| Feb 23, 2026 | Feb 23, 2026 | Birkemeyer Elaine M. | TCMD | CHIEF FINANCIAL OFFICER | Form 144 notice | 5,518 | $156k | Notice | SEC | |
| Jan 2, 2026 | Jan 6, 2026 | Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Form 4 sale | 5,139 | $148k | 6.6% | Routine | SEC |
| Jan 2, 2026 | Jan 2, 2026 | Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Form 144 notice | 5,139 | $148k | Notice | SEC | |
| Aug 8, 2025 | Aug 12, 2025 | Dodd Sheri Louise | TCMD | Chief Executive Officer | Form 4 sale | 7,762 | $96k | 4.3% | No plan | SEC |
| Aug 8, 2025 | Aug 8, 2025 | Dodd Sheri Louise | TCMD | Chief Executive Officer | Form 144 notice | 7,762 | $96k | Notice | SEC | |
| May 12, 2025 | May 14, 2025 | Birkemeyer Elaine M. | TCMD | Chief Financial Officer | Form 4 sale | 2,921 | $29k | 2.9% | Routine | SEC |
| May 12, 2025 | May 12, 2025 | Birkemeyer Elaine M. | TCMD | CHIEF FINANCIAL OFFICER | Form 144 notice | 2,921 | $29k | Notice | SEC | |
| May 8, 2025 | May 12, 2025 | Dodd Sheri Louise | TCMD | Chief Executive Officer | Form 4 sale | 3,149 | $31k | 1.7% | No plan | SEC |
| May 8, 2025 | May 9, 2025 | Burke William W | TCMD | Director | Form 4 sale | 3,300 | $32k | 6.4% | Routine | SEC |
| May 8, 2025 | May 8, 2025 | Dodd Sheri Louise | TCMD | Chief Executive Officer | Form 144 notice | 3,149 | $31k | Notice | SEC | |
| May 8, 2025 | May 8, 2025 | Burke William W | TCMD | Director | Form 144 notice | 3,300 | $32k | Notice | SEC | |
| Apr 3, 2025 | Apr 3, 2025 | Ferstler Sherri Lee | TCMD | Senior VP, Sales | Form 144 notice | 2,355 | $31k | Notice | SEC | |
| Feb 25, 2025 | Feb 27, 2025 | Birkemeyer Elaine M. | TCMD | Chief Financial Officer | Form 4 sale | 2,066 | $30k | 2.0% | Routine | SEC |
| Feb 25, 2025 | Feb 27, 2025 | Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Form 4 sale | 6,468 | $93k | 7.7% | Unusual | SEC |
| Feb 25, 2025 | Feb 27, 2025 | Reuvers Daniel L. | TCMD | Director | Form 4 sale | 28,338 | $402k | 11.7% | Unusual | SEC |
| Feb 25, 2025 | Feb 25, 2025 | Reuvers Daniel L. | TCMD | Director | Form 144 notice | 28,338 | $402k | Notice | SEC | |
| Feb 25, 2025 | Feb 25, 2025 | Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Form 144 notice | 6,468 | $93k | Notice | SEC | |
| Feb 25, 2025 | Feb 25, 2025 | Birkemeyer Elaine M. | TCMD | CHIEF FINANCIAL OFFICER | Form 144 notice | 2,066 | $30k | Notice | SEC | |
| Feb 24, 2025 | Feb 24, 2025 | Reuvers Daniel L. | TCMD | Director | Form 144 notice | 10,938 | $159k | Notice | SEC | |
| Feb 24, 2025 | Feb 24, 2025 | Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Form 144 notice | 4,830 | $71k | Notice | SEC | |
| Feb 24, 2025 | Feb 24, 2025 | Ferstler Sherri Lee | TCMD | Senior VP, Sales | Form 144 notice | 2,209 | $33k | Notice | SEC | |
| Feb 24, 2025 | Feb 24, 2025 | Birkemeyer Elaine M. | TCMD | CHIEF FINANCIAL OFFICER | Form 144 notice | 3,778 | $56k | Notice | SEC | |
| Feb 24, 2025 | Feb 24, 2025 | Reuvers Daniel L. | TCMD | Director | Form 4 sale | 10,938 | $159k | 4.3% | Routine | SEC |
| Feb 24, 2025 | Feb 24, 2025 | Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Form 4 sale | 4,830 | $71k | 5.4% | Unusual | SEC |
| Feb 24, 2025 | Feb 24, 2025 | Birkemeyer Elaine M. | TCMD | Chief Financial Officer | Form 4 sale | 3,778 | $56k | 3.5% | Routine | SEC |
| Aug 12, 2024 | Aug 14, 2024 | Ferstler Sherri Lee | TCMD | Senior VP, Sales | Form 4 sale | 1,550 | $20k | 3.8% | No plan | SEC |
| Aug 12, 2024 | Aug 12, 2024 | Ferstler Sherri Lee | TCMD | Senior VP, Sales | Form 144 notice | 1,550 | $20k | Notice | SEC | |
| May 16, 2024 | May 20, 2024 | Birkemeyer Elaine M. | TCMD | Chief Financial Officer | Form 4 sale | 3,041 | $42k | 4.7% | No plan | SEC |
| May 16, 2024 | May 16, 2024 | Birkemeyer Elaine M. | TCMD | CHIEF FINANCIAL OFFICER | Form 144 notice | 3,041 | $42k | Notice | SEC | |
| May 8, 2024 | May 10, 2024 | Burke William W | TCMD | Director | Form 4 sale | 2,500 | $35k | 9.0% | Routine | SEC |
| May 8, 2024 | May 8, 2024 | Burke William W | TCMD | Director | Form 144 notice | 2,500 | $35k | Notice | SEC |